Skip to main content

Table 2 Klotho, FGF19, and FGF21 concentrations in correlation with age, parameters of nutritional status, lipid and glucose profiles, ALT and HOMA-IR

From: Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters

 KlothoFGF19FGF21
AgeR = 0.053, p = 0.4848R = 0.064, p = 0.3996R = 0.159, p = 0.0360
BMI Z-scoreR = 0.188, p = 0.0129R = -0.206, p = 0.0062R = 0.111, p = 0.1423
BF%R = 0.210, p = 0.0055R = −0.143, p = 0.0600R = 0.202, p = 0.0020
ALTR = 0.184, p = 0.0149R = -0.230, p = 0.0022R = 0.015, p = 0.8413
TCR = 0.097, p = 0.1997R = −0.040, p = 0.5913R = -0.050, p = 0.5057
HDL-CR = 0.084, p = 0.2649R = 0.122, p = 0.1076R = -0.212, p = 0.0047
LDL-CR = 0.211, p = 0.0051R = −0.030, p = 0.6852R = 0.087, p = 0.2504
TGsR = -0.014, p = 0.8507R = −0.201, p = 0.0077R = 0.187, p = 0.0131
Fasting glucoseR = −0,029, p = 0,7082R = − 0,096, p = 0,2106R = − 0,084, p = 0,2726
HOMA-IRR = 0.129, p = 0.0879R = − 0.313, p < 0.0001R = 0.098, p = 0.1978
  1. HOMA-IR Homeostatic Model Assessment of Insulin Resistance, BMI body mass index, BF% body fat [%], TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TGs triglycerides, ALT alanine aminotransferase, FGF19 fibroblast growth factor 19, FGF21 fibroblast growth factor 21